CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that Biosensing Instrument has been named an AZBio Fast Lane Company and will be honored on October 2, 2019 at the AZBio Awards.

“Developing a new drug is one of the most expensive and complex innovation challenges,” stated Joan Koerber-Walker, president & CEO of AZBio.  “Biosensing Instrument, Inc. (BI), a Tempe based life science company, is transforming early drug discovery research at pharmaceuticals and academic laboratories around the world by enabling measurements that were not possible before.”Continue reading→

Continue reading→

Arizona Commerce Authority opens application window for the Fall 2019 Arizona Innovation Challenge.

Applications will be accepted beginning on Thursday, September 5 through Friday, September 27 at 5 p.m MST

Learn more and apply at azcommerce.com/programs/arizona-innovation-challenge/apply/
Continue reading→

TUCSON, Ariz. – Professor of Medicine and Phase 1 Program Director at the University of Arizona Cancer Center and the College of Medicine – Tucson Daruka Mahadevan, MD/PhD, has been recognized as a Senior Member of the National Academy of Inventors.Continue reading→

Peers will help newly diagnosed sleep-apnea patients get the most out of CPAP treatment, which saves lives but is difficult for many patients to follow.Continue reading→

On April 3, 2019, the Small Business Association (SBA) released a revised Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program policy directive, which went into effect May 2, 2019 (the “New Policy”).¹ This New Policy made important and drastic changes to Data Rights protections afforded to SBIR/STTR awarded small business companies. Government contractors should understand these major changes and consider the impact on company operations related to commercialization of intellectual property developed with government funding.Continue reading→

The F900 is the Most Capable System on the Market for Companies Who Need Large, 3D-Printed Production Parts in Small or Large Volume.Continue reading→

 This launch represents an important step in Roche’s personalised healthcare strategy to fit treatments to patients who can benefit most from a specific medicine.

Each year 300,000 patients around the world are diagnosed with triple-negative breast cancer, an aggressive disease with limited treatment options1,2

VENTANA PD-L1 (SP142) Assay helps identify triple-negative breast cancer patients most likely to benefit from treatment with Tecentriq plus chemotherapy

Continue reading→

CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that OncoMyx Therapeutics, Inc.  has been named an AZBio Fast Lane Company and will be honored on October 2, 2019 at the AZBio Awards.Continue reading→